CXCR4 and cancer: Thus far, CXCR4 has been a major target for the therapy of different cancers, either by blocking antibodies or small molecules, among them BKT140, bicyclam AMD070, AMD3100, AMD11070, MSX-122, GSK812397, KRH-3955, and several small modified peptides (reviewed in [9]).